Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (291-300 of 999) with videos related to

Pageof 100
Sort By:
American Journal of Preventive Cardiology|November 8, 2021
Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statinsHarold E Bays, Seth J Baum, Eliot A Brinton, et al.
American Heart Journal|June 7, 2011
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelinesSalim S Virani, Lechauncy D Woodard, Cassie R Landrum, et al.
Journal of Virology|July 22, 2011
CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infectionSariah J Allen, Kevin R Mott, Aziz A Chentoufi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 20, 2010
Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI StudyJohn W Gaubatz, Christie M Ballantyne, Bruce A Wasserman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2014
Dual role of the leukocyte integrin αMβ2 in angiogenesisDmitry A Soloviev, Stanley L Hazen, Dorota Szpak, et al.
Diabetologia|December 1, 2006
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities StudyR C Hoogeveen, C M Ballantyne, H Bang, et al.
Blood|May 30, 2008
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesElzbieta Pluskota, Neil M Woody, Dorota Szpak, et al.
Cardiovascular Drugs and Therapy|March 19, 2011
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglyceridesChristie M Ballantyne, Peter H Jones, Maureen T Kelly, et al.
Lipids in Health and Disease|September 5, 2015
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease riskJeffrey B Rosen, Christie M Ballantyne, Willa A Hsueh, et al.
Atherosclerosis|April 27, 1999
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsH J Pownall, D Brauchi, C Kilinç, et al.
Pageof 100

Showing results (291-300 of 999) with videos related to

Sort By:
Pageof 100
American Journal of Preventive Cardiology|November 8, 2021
Effect of bempedoic acid plus ezetimibe fixed-dose combination vs ezetimibe or placebo on low-density lipoprotein cholesterol in patients with type 2 diabetes and hypercholesterolemia not treated with statinsHarold E Bays, Seth J Baum, Eliot A Brinton, et al.
American Heart Journal|June 7, 2011
Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the Adult Treatment Panel III guidelinesSalim S Virani, Lechauncy D Woodard, Cassie R Landrum, et al.
Journal of Virology|July 22, 2011
CD11c controls herpes simplex virus 1 responses to limit virus replication during primary infectionSariah J Allen, Kevin R Mott, Aziz A Chentoufi, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 20, 2010
Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI StudyJohn W Gaubatz, Christie M Ballantyne, Bruce A Wasserman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 28, 2014
Dual role of the leukocyte integrin αMβ2 in angiogenesisDmitry A Soloviev, Stanley L Hazen, Dorota Szpak, et al.
Diabetologia|December 1, 2006
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities StudyR C Hoogeveen, C M Ballantyne, H Bang, et al.
Blood|May 30, 2008
Expression, activation, and function of integrin alphaMbeta2 (Mac-1) on neutrophil-derived microparticlesElzbieta Pluskota, Neil M Woody, Dorota Szpak, et al.
Cardiovascular Drugs and Therapy|March 19, 2011
Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglyceridesChristie M Ballantyne, Peter H Jones, Maureen T Kelly, et al.
Lipids in Health and Disease|September 5, 2015
Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease riskJeffrey B Rosen, Christie M Ballantyne, Willa A Hsueh, et al.
Atherosclerosis|April 27, 1999
Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteinsH J Pownall, D Brauchi, C Kilinç, et al.
Pageof 100